SANTA ROSA, Calif.--(BUSINESS WIRE)--Endologix LLC, a privately held, global medical device company focused on advancing innovative therapies for the interventional treatment of vascular disease, today announced the acquisition of the Pounce™...
SANTA ROSA, Calif.--(BUSINESS WIRE)--Endologix LLC, a privately held, global medical device company focused on advancing innovative therapies for the interventional treatment of vascular disease, today announced the acquisition of the Pounce™...
EMPOWER CAD, a global prospective, multi-center, real-world study, reaffirms favorable acute outcomes for coronary IVL in female patients, unlike other calcium modification tools.
EMPOWER CAD, a global prospective, multi-center, real-world study, reaffirms favorable acute outcomes for coronary IVL in female patients, unlike other calcium modification tools.
Financing supports clinical advancement and commercialization of the company’s dual-modality IVL platform, with proceeds funding peripheral commercial launch and coronary program development.
Financing supports clinical advancement and commercialization of the company’s dual-modality IVL platform, with proceeds funding peripheral commercial launch and coronary program development.
Late-breaking data from global pivotal study achieved high rates of freedom from major adverse cardiac events and procedural success in patients with severe coronary artery disease.
Late-breaking data from global pivotal study achieved high rates of freedom from major adverse cardiac events and procedural success in patients with severe coronary artery disease.
Newly issued patents in Australia and Japan cover the company's Artero™ E-IVL and Sola™ L-IVL platforms as FastWave advances toward peripheral and coronary IDE trials.
Newly issued patents in Australia and Japan cover the company's Artero™ E-IVL and Sola™ L-IVL platforms as FastWave advances toward peripheral and coronary IDE trials.
The eLym System is an investigational catheter-based device for treating patients with acute decompensated heart failure (ADHF) by supporting lymphatic drainage.
The eLym System is an investigational catheter-based device for treating patients with acute decompensated heart failure (ADHF) by supporting lymphatic drainage.
Orchestra BioMed targeting enrollment completion of BACKBEAT Global Pivotal Trial (“BACKBEAT Trial”) by the end of Q3 2026
Orchestra BioMed and Medtronic plc, the Company’s strategic collaborator for the BACKBEAT Trial,...
Orchestra BioMed targeting enrollment completion of BACKBEAT Global Pivotal Trial (“BACKBEAT Trial”) by the end of Q3 2026
Orchestra BioMed and Medtronic plc, the Company’s strategic collaborator for the BACKBEAT Trial,...
The Optiq AI imaging chain common to all six systems uses AI to analyze and optimize image data in real time. The six new systems address a wide range of clinical uses, operational needs, and financial considerations.
The Optiq AI imaging chain common to all six systems uses AI to analyze and optimize image data in real time. The six new systems address a wide range of clinical uses, operational needs, and financial considerations.
“Shockwave C2 Aero makes it easier to navigate tortuous coronary anatomy without relying on additional upfront ancillary devices," said Margaret McEntegart, MD, PhD.
“Shockwave C2 Aero makes it easier to navigate tortuous coronary anatomy without relying on additional upfront ancillary devices," said Margaret McEntegart, MD, PhD.
